Association of hepcidin promoter c.-582 A>G variant and iron overload in thalassemia major

Haematologica

Volumn 94, Issue 9, 2009, Pages 1293-1296

  Andreani, Marco ^a   Radio, Francesca Clementina ^d   Testi, Manuela ^a   De Bernardo, Carmelilia ^d   Troiano, Maria ^a   Majore, Silvia ^d   Bertucci, Pierfrancesco ^c   Polchi, Paola ^b   Rosati, Renata ^a   Grammatico, Paola ^d  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^b IME Foundation   (Italy)

^c S Camillo Hospital ^*  (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

thalassemia; HAMP; HFE; Iron metabolism; Liver iron concentration

Indexed keywords

FERRITIN; HEPCIDIN; IRON;

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CHILD; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; GENE; GENE FUNCTION; HEMOCROMATOSIS GENE; HUMAN; HUMAN TISSUE; IRON METABOLISM; IRON OVERLOAD; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHILD; FEMALE; HUMANS; IRON; IRON OVERLOAD; MALE; MICE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 70349104225     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.006270     Document Type: Article

References (24)

1. Andrews NC. Forging a field: the golden age of iron biology. Blood 2008;112:219-230
2. Piperno A. Classification and diagnosis of iron overload. Haematologica 1998; 83:447-455
3. Ganz T. Hepcidin - a peptide hormone at the interface of innate immunity and iron metabolism. Curr Top Microbiol Immunol 2006;306:183-198 (Pubitemid 47400322)
4. Kemna EH, Tjalsma H, Willems HL, Swinkels DW. Hepcidin: from discovery to differential diagnosis. Haematologica 2008;93:90-97
5. Bayele HK, McArdle H, Srai SK. Cis and trans regulation of hepcidin expression by upstream stimulatory factor. Blood 2006;108:4237-4245 (Pubitemid 44913299)
6. Ganz T. Hepcidin and its role in regulating systemic iron metabolism. Hematology Am Soc Hematol Educ Program 2006;507:29-35.
7. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003;101:2461-2463 (Pubitemid 36857598)
8. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002;110:1037-1044
9. Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 2002;100:3776-3781
10. Peyssonnaux C, Zinkernagel AS, Schuepbach RA, Rankin E, Vaulont S, Haase VH, et al. Regulation of iron homeostasis by the hypoxiainducible transcription factors (HIFs). J Clin Invest 2007;117:1926-1932.
11. Origa R, Galanello R, Ganz T, Giagu N, Maccioni L, Faa G, et al. Liver iron concentrations and urinary hepcidin in β-thalassemia. Haematologica 2007;92:583-588 (Pubitemid 350144260)
12. Kattamis A, Papassotiriou I, Palaiologou D, Apostolakou F, Galani A, Ladis V, et al. The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major. Haematologica 2006;91:809-812 (Pubitemid 44014549)
13. Camberlein E, Zanninelli G, Détivaud L, Lizzi AR, Sorrentino F, Vacquer S, et al. Anemia in β-thalassemia patients targets hepatic hepcidin transcript levels independently of iron metabolism genes controlling hepcidin expression. Haematologica 2008;93:111-115 (Pubitemid 351156158)
14. Gardenghi S, Marongiu MF, Ramos P, Guy E, Breda L, Chadburn A, et al. Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood 2007;109:5027-5035 (Pubitemid 46827803)
15. Kearney SL, Nemeth E, Neufeld EJ, Thapa D, Ganz T, Weinstein DA, Cunningham MJ. Urinary hepcidin in congenital chronic anemias. Pediatr Blood Cancer 2007;48:57-63. (Pubitemid 44871594)
16. Hanson EH, Imperatore G, Burke W. HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. Am J Epidemiol 2001;154:193-206.
17. Melis MA, Cau M, Deidda F, Barella S, Cao A, Galanello R. H63D mutation in the HFE gene increases iron overload in β-thalassemia carriers. Haematologica 2002;87:242-245 (Pubitemid 34212438)
18. Pietrangelo A, Trautwein C. Mechanisms of disease: the role of hepcidin in iron homeostasis-implications for hemochromatosis and other disorders. Nat Clin Pract Gastroenterol Hepatol 2004;1:39-45. (Pubitemid 40823692)
19. Yamsri S, Sanchaisuriya K, Fucharoen S, Fucharoen G, Jetsrisuparb A, Wiangnon S, et al. H63D mutation of the hemochromatosis gene and serum ferritin levels in Thai thalassemia carriers. Acta Haematol 2007;118:99-105. (Pubitemid 47413793)
20. Le Gac G, Férec C. The molecular genetics of haemochromatosis. Eur J Hum Genet 2005;13:1172-1185
21. Politou M, Kalotychou V, Pissia M, Rombos Y, Sakellaropoulos N, Papanikolaou G. The impact of the mutations of the HFE gene and of the SLC11A3 gene on iron overload in Greek thalassemia intermedia and β(s)/β(thal) anemia patients. Haematologica 2004;89:490-492 (Pubitemid 38798554)
22. Angelucci E, Brittenham GM, McLaren CE, Ripalti M, Baronciani D, Giardini C, et al. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med 2000;343:327-331 (Pubitemid 30616698)
23. Brittenham GM, Cohen AR, McLaren CE, Martin MB, Griffith PM, Nienhuis AW, et al. Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. Am J Hematol 1993;42:81-85
24. Angelucci E, Baronciani D, Lucarelli G, Baldassarri M, Galimberti M, Giardini C, et al. Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies. Br J Haematol 1995;89:757-761